(Q35147127)
Statements
Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton (English)
Bogdanos J
Karamanolakis D
Tsintavis A
Milathianakis C
Mitsiades C